{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:03:33Z","timestamp":1784786613310,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T00:00:00Z","timestamp":1703980800000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.lungcan.2022.12.011","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T20:19:57Z","timestamp":1671653997000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Economic impact of using risk models for eligibility selection to the International lung screening Trial"],"prefix":"10.1016","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4769-8082","authenticated-orcid":false,"given":"Sonya","family":"Cressman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne F.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preston J.","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Behar Harpaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Caruana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Manser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhinder","family":"Atkar-Khattra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deme","family":"Karikios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleisha","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yi Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renelle","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry M","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwun M","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C","family":"Tammem\u00e4gi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lungcan.2022.12.011_b0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med."},{"issue":"6","key":"10.1016\/j.lungcan.2022.12.011_b0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med."},{"issue":"7","key":"10.1016\/j.lungcan.2022.12.011_b0015","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/annonc\/mdz117","article-title":"Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy","volume":"30","author":"Pastorino","year":"2019","journal-title":"Ann Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2022.12.011_b0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/M13-2771","article-title":"Force on behalf of the US Preventative Services Task Force. Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.lungcan.2022.12.011_b0025","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jamaoncol.2019.1402","article-title":"Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers","volume":"5","author":"Aldrich","year":"2019","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.12.011_b0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s40615-018-0492-z","article-title":"Potential Racial Disparities Using Current Lung Cancer Screening Guidelines","volume":"6","author":"Annangi","year":"2019","journal-title":"J. Racial Ethn. Health Disparities"},{"issue":"10","key":"10.1016\/j.lungcan.2022.12.011_b0035","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1001\/jama.2021.1077","article-title":"Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force","volume":"325","author":"Meza","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.lungcan.2022.12.011_b0040","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement","volume":"325","author":"US Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.lungcan.2022.12.011_b0045","doi-asserted-by":"crossref","unstructured":"Landy R, Young CD, Skarzynski M, Cheung LC, Berg CD, Rivera MP, et al. Using Prediction-Models to Reduce Persistent Racial\/Ethnic Disparities in Draft 2020 USPSTF Lung-Cancer Screening Guidelines. Journal of the National Cancer Institute. 2021;113(11):1590\u201394.","DOI":"10.1093\/jnci\/djaa211"},{"issue":"2","key":"10.1016\/j.lungcan.2022.12.011_b0050","doi-asserted-by":"crossref","first-page":"e1001376","DOI":"10.1371\/journal.pmed.1001376","article-title":"Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis","volume":"10","author":"Forrest","year":"2013","journal-title":"PLoS Med."},{"issue":"6","key":"10.1016\/j.lungcan.2022.12.011_b0055","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/hec.3058","article-title":"Distributional cost-effectiveness analysis of health care programmes\u2014a methodological case study of the UK Bowel Cancer Screening Programme","volume":"24","author":"Asaria","year":"2015","journal-title":"Health Econ."},{"key":"10.1016\/j.lungcan.2022.12.011_b0060","doi-asserted-by":"crossref","unstructured":"Lebrett MB, Balata H, Evison M, Colligan D, Duerden R, Elton P, et al. Analysis of lung cancer risk model (PLCOM2012 LLPv2) performance in a community-based lung cancer screening programme. Thorax. 2020:75(8): 661\u201368.","DOI":"10.1136\/thoraxjnl-2020-214626"},{"issue":"1","key":"10.1016\/j.lungcan.2022.12.011_b0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.chest.2021.06.066","article-title":"Addressing Sex Disparities in Lung Cancer Screening Eligibility: USPSTF vs PLCOm2012 Criteria","volume":"161","author":"Pasquinelli","year":"2022","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.lungcan.2022.12.011_b0070","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.jtho.2020.08.006","article-title":"Risk Prediction Model Versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing Race Disparities","volume":"15","author":"Pasquinelli","year":"2020","journal-title":"J Thorac Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2022.12.011_b0075","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S1470-2045(17)30597-1","article-title":"Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study","volume":"18","author":"Tammemagi","year":"2017","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2022.12.011_b0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/thoraxjnl-2015-207140","article-title":"UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening","volume":"71","author":"Field","year":"2016","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.lungcan.2022.12.011_b0085","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1513\/AnnalsATS.201902-102OC","article-title":"Protocol and Rationale for the International Lung Screening Trial","volume":"17","author":"Lim","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.lungcan.2022.12.011_b0090","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1470-2045(21)00590-8","article-title":"USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study","volume":"23","author":"Tammem\u00e4gi","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2022.12.011_b0095","doi-asserted-by":"crossref","unstructured":"Attema AE, Brouwer WBF, Claxton K. Discounting in Economic Evaluations PharmacoEconomics. 2018;36(7):745\u201358.","DOI":"10.1007\/s40273-018-0672-z"},{"issue":"2","key":"10.1016\/j.lungcan.2022.12.011_b0100","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1177\/0272989X98018002S09","article-title":"Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis","volume":"18","author":"Stinnett","year":"1998","journal-title":"Med Decis Making."},{"key":"10.1016\/j.lungcan.2022.12.011_b0105","unstructured":"Cancer Australia. Report on the Lung Cancer Screening Enquiry. Surry Hills, NSW Cancer Australia; 2020. Available at: https:\/\/www.canceraustralia.gov.au\/publications-and-resources\/cancer-australia-publications\/report-lung-cancer-screening-enquiry (accessed [2022]."},{"issue":"2","key":"10.1016\/j.lungcan.2022.12.011_b0110","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/S2468-2667(16)30019-6","article-title":"Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis","volume":"1","author":"Simms","year":"2016","journal-title":"Lancet Public Health."},{"key":"10.1016\/j.lungcan.2022.12.011_b0115","unstructured":"Canadian Cancer Society. Canadian Cancer Statistics: A 2020 special report on lung cancer. 2020; Available at: cancer.ca\/Canadian-Cancer-Statistics-2020-EN. (Accessed [2022])."},{"key":"10.1016\/j.lungcan.2022.12.011_b0120","unstructured":"Statistics Canada. Table 13-10-0710-01 Mortality rates, by age group. 10.25318\/1310071001-eng. 2022. (Accessed [2022])."},{"issue":"10","key":"10.1016\/j.lungcan.2022.12.011_b0125","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/JTO.0000000000000283","article-title":"Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada","volume":"9","author":"Cressman","year":"2014","journal-title":"J Thorac Oncol."},{"issue":"11","key":"10.1016\/j.lungcan.2022.12.011_b0130","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/imj.14439","article-title":"Cost of screening for lung cancer in Australia","volume":"49","author":"Marshall","year":"2019","journal-title":"Intern Med J."},{"issue":"8","key":"10.1016\/j.lungcan.2022.12.011_b0135","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jtho.2017.04.021","article-title":"The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency","volume":"12","author":"Cressman","year":"2017","journal-title":"J Thorac Oncol."},{"key":"10.1016\/j.lungcan.2022.12.011_b0140","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lungcan.2022.05.003","article-title":"Health utilities for participants in a population-based sample who meet eligibility criteria for lung cancer screening","volume":"169","author":"Ngo","year":"2022","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.lungcan.2022.12.011_b0145","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0272989X15570364","article-title":"Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study","volume":"35","author":"Tramontano","year":"2015","journal-title":"Med Decis Making."},{"issue":"12","key":"10.1016\/j.lungcan.2022.12.011_b0150","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/JTO.0b013e3181f77a6a","article-title":"Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer","volume":"5","author":"Jang","year":"2010","journal-title":"J Thorac Oncol."},{"key":"10.1016\/j.lungcan.2022.12.011_b0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40985-018-0100-0","article-title":"Participation in lung cancer screening programs: are there gender and social differences?","volume":"39","author":"Sch\u00fctte","year":"2018","journal-title":"A systematic review. Public Health Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2022.12.011_b0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12874-016-0247-7","article-title":"Why sex and gender matter in implementation research","volume":"16","author":"Tannenbaum","year":"2016","journal-title":"BMC Med Res Methodol."},{"issue":"6","key":"10.1016\/j.lungcan.2022.12.011_b0165","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.athoracsur.2020.07.051","article-title":"Organized Lung Cancer Screening Pilot: Informing a Province-Wide Program in Ontario Canada","volume":"111","author":"Darling","year":"2021","journal-title":"Ann Thorac Surg."},{"key":"10.1016\/j.lungcan.2022.12.011_b0170","unstructured":"National Health Service of the United Kingdom. Targeted Screening for Lung Cancer with Low Radiation Dose Computed Tomography. Standard Protocol prepared for the Targeted Lung Health Checks Programme. 2022. Available at: https:\/\/www.england.nhs.uk\/publication\/targeted-screening-for-lung-cancer\/ (Accessed [2022])."},{"issue":"12","key":"10.1016\/j.lungcan.2022.12.011_b0175","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1038\/s41416-021-01278-0","article-title":"Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom","volume":"124","author":"Robbins","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2022.12.011_b0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M17-2701","article-title":"Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening","volume":"169","author":"Katki","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2022.12.011_b0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40471-016-0069-5","article-title":"The Consistency Assumption for Causal Inference in Social Epidemiology: When a Rose is Not a Rose","volume":"3","author":"Rehkopf","year":"2016","journal-title":"Curr Epidemiol Rep."},{"key":"10.1016\/j.lungcan.2022.12.011_b0190","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lungcan.2022.02.009","article-title":"Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods","volume":"166","author":"Ngo","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2022.12.011_b0195","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2019.09.026","article-title":"Valuing preferences for treating screen detected ductal carcinoma in situ","volume":"123","author":"Bromley","year":"2019","journal-title":"Eur J Cancer."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222007206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222007206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:02:35Z","timestamp":1759237355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222007206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":39,"alternative-id":["S0169500222007206"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.12.011","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic impact of using risk models for eligibility selection to the International lung screening Trial","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}